229 related articles for article (PubMed ID: 32961022)
1. Evaluation of B-cell intracellular signaling by monitoring the PI3K-Akt axis in patients with common variable immunodeficiency and activated phosphoinositide 3-kinase delta syndrome.
Del Pino-Molina L; Torres Canizales JM; Rodríguez-Pena R; López-Granados E
Cytometry B Clin Cytom; 2021 Jul; 100(4):460-466. PubMed ID: 32961022
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated PI3K Signaling in B Cells of CVID Patients.
Harder I; Münchhalfen M; Andrieux G; Boerries M; Grimbacher B; Eibel H; Maccari ME; Ehl S; Wienands J; Jellusova J; Warnatz K; Keller B
Cells; 2022 Jan; 11(3):. PubMed ID: 35159274
[TBL] [Abstract][Full Text] [Related]
3. Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
Asano T; Okada S; Tsumura M; Yeh TW; Mitsui-Sekinaka K; Tsujita Y; Ichinose Y; Shimada A; Hashimoto K; Wada T; Imai K; Ohara O; Morio T; Nonoyama S; Kobayashi M
Front Immunol; 2018; 9():568. PubMed ID: 29675019
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency.
Tsujita Y; Mitsui-Sekinaka K; Imai K; Yeh TW; Mitsuiki N; Asano T; Ohnishi H; Kato Z; Sekinaka Y; Zaha K; Kato T; Okano T; Takashima T; Kobayashi K; Kimura M; Kunitsu T; Maruo Y; Kanegane H; Takagi M; Yoshida K; Okuno Y; Muramatsu H; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Kojima S; Ogawa S; Ohara O; Okada S; Kobayashi M; Morio T; Nonoyama S
J Allergy Clin Immunol; 2016 Dec; 138(6):1672-1680.e10. PubMed ID: 27426521
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency.
Visentini M; Marrapodi R; Conti V; Mitrevski M; Camponeschi A; Lazzeri C; Carbonari M; Catizone A; Quinti I; Fiorilli M
J Allergy Clin Immunol; 2014 Aug; 134(2):401-10. PubMed ID: 24792875
[TBL] [Abstract][Full Text] [Related]
6. Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.
Wentink M; Dalm V; Lankester AC; van Schouwenburg PA; Schölvinck L; Kalina T; Zachova R; Sediva A; Lambeck A; Pico-Knijnenburg I; van Dongen JJ; Pac M; Bernatowska E; van Hagen M; Driessen G; van der Burg M
Clin Immunol; 2017 Mar; 176():77-86. PubMed ID: 28104464
[TBL] [Abstract][Full Text] [Related]
7. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency.
Yazdani R; Ganjalikhani-Hakemi M; Esmaeili M; Abolhassani H; Vaeli S; Rezaei A; Sharifi Z; Azizi G; Rezaei N; Aghamohammadi A
Clin Immunol; 2017 Feb; 175():124-132. PubMed ID: 27664934
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Poopal AC; Schroeder LM; Horn PS; Bassell GJ; Gross C
Mol Autism; 2016; 7():3. PubMed ID: 26770665
[TBL] [Abstract][Full Text] [Related]
9. Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients.
Del Pino Molina L; Torres Canizales JM; Pernía O; Rodríguez Pena R; Ibanez de Caceres I; López Granados E
Clin Exp Immunol; 2021 Mar; 203(3):341-350. PubMed ID: 32961586
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
11. Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase δ Syndrome.
Wang Y; Wang W; Liu L; Hou J; Ying W; Hui X; Zhou Q; Liu D; Yao H; Sun J; Wang X
J Clin Immunol; 2018 Nov; 38(8):854-863. PubMed ID: 30499059
[TBL] [Abstract][Full Text] [Related]
12. CD19 controls Toll-like receptor 9 responses in human B cells.
Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
Liu Y; Fanburg BL
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
[TBL] [Abstract][Full Text] [Related]
14. Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disorders.
Cooley Coleman JA; Gass JM; Srikanth S; Pauly R; Ziats CA; Everman DB; Skinner SA; Bell S; Louie RJ; Cascio L; Patterson WG; Jones JR; Di Donato N; Stevenson RE; Boccuto L
Hum Mol Genet; 2023 Apr; 32(9):1457-1465. PubMed ID: 36458889
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.
Minhajuddin M; Bijli KM; Fazal F; Sassano A; Nakayama KI; Hay N; Platanias LC; Rahman A
J Biol Chem; 2009 Feb; 284(7):4052-61. PubMed ID: 19074768
[TBL] [Abstract][Full Text] [Related]
16. A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.
Negishi Y; Miya F; Hattori A; Johmura Y; Nakagawa M; Ando N; Hori I; Togawa T; Aoyama K; Ohashi K; Fukumura S; Mizuno S; Umemura A; Kishimoto Y; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Nakanishi M; Saitoh S
BMC Med Genet; 2017 Jan; 18(1):4. PubMed ID: 28086757
[TBL] [Abstract][Full Text] [Related]
17. Activated phosphoinositide 3-dinase delta syndrome (APDS): An update.
Lougaris V; Cancrini C; Rivalta B; Castagnoli R; Giardino G; Volpi S; Leonardi L; La Torre F; Federici S; Corrente S; Cinicola BL; Soresina A; Marseglia GL; Cardinale F
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):69-72. PubMed ID: 35080319
[TBL] [Abstract][Full Text] [Related]
18. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
20. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.
Bilancio A; Okkenhaug K; Camps M; Emery JL; Ruckle T; Rommel C; Vanhaesebroeck B
Blood; 2006 Jan; 107(2):642-50. PubMed ID: 16179367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
